A Study to Evaluate the Clinical Epidemiology of Patients With Heart Failure (HF) in India
A Non-interventional, Prospective Study to Evaluate the Clinical Epidemiology of Patients With Heart Failure (HF) in India
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
This non-interventional, prospective, multi-centric, cross-sectional study is aimed to observe clinical practice in India in managing Heart Failure patients \& to check one year outcome in HF patients. A total of 5 visits will be conducted during the study. There will be a baseline visit followed by four follow-up visits to assess the outcomes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2013
CompletedStudy Start
First participant enrolled
November 1, 2013
CompletedFirst Posted
Study publicly available on registry
January 28, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedJanuary 28, 2014
January 1, 2014
8 months
February 6, 2013
January 27, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Cardiovascular hospitalization rates and Length of stay
1 year
HF related Hospitalization and hospital visits
1 year
Cardiovascular and all cause mortality
1 year
Change in Minnesota Living with Heart Failure Questionnaire scores.
1 year
Study Arms (1)
1
Eligibility Criteria
All patients with Dyspnea and/or signs of systemic congestion
You may qualify if:
- Provision of subject informed consent
- Female or male aged 18 years and over
- All patients with Dyspnea and/or signs of systemic congestion
You may not qualify if:
- Subjects with Current Acute Coronary Syndrome
- Absence of cardiac disease/structural heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ammar Raza, MBBS, DIP DIAB, MBA
AstraZeneca Pharma India Ltd.
- PRINCIPAL INVESTIGATOR
R R Kasliwal, DM
Medanta, The Medicity, Gurgaon
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2013
First Posted
January 28, 2014
Study Start
November 1, 2013
Primary Completion
July 1, 2014
Last Updated
January 28, 2014
Record last verified: 2014-01